Assessing the attitudes, knowledge, and awareness of HIV vaccine research among adults in the United States

Journal of Acquired Immune Deficiency Syndromes

Volumn 40, Issue 5, 2005, Pages 617-624

  Allen, Mary A ^a   Liang, Thomas S ^a   La Salvia, Thomas ^b   Tjugum, Brian ^c   Gulakowski, Robert J ^a   Murguía, Matthew ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c Ogilvy Public Relations Worldwide   (United States)

Author keywords

Attitudes; HIV; Racial and ethnic minorities; Survey; Vaccine

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS VACCINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AFRICAN AMERICAN; AGED; ARTICLE; ATTITUDE; AWARENESS; EPIDEMIC; FEMALE; HISPANIC; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERVIEW; MALE; MEDICAL RESEARCH; PRIORITY JOURNAL; RACE; UNITED STATES;

ADOLESCENT; ADULT; AFRICAN AMERICANS; AGED; AIDS VACCINES; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH SURVEYS; HISPANIC AMERICANS; HIV INFECTIONS; HOMOSEXUALITY, MALE; HUMANS; MALE; MIDDLE AGED; QUESTIONNAIRES; RESEARCH; UNITED STATES;

EID: 27944487492     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.qai.0000174655.63653.38     Document Type: Article

References (15)

1. Centers for Disease Control and Prevention. HIV/AIDS Surveillance Report, vol. 14. Atlanta, GA: Centers for Disease Control and Prevention; 2002.
2. Centers for Disease Control and Prevention. HIV and AIDS: United States, 1981-2001. MMWR Morb Mortal Wkly Rep. 2001;50:430-434.
3. Centers for Disease Control and Prevention (CDC). HIV Prevention Strategic Plan Through 2005. Atlanta, GA: Centers for Disease Control and Prevention; 2001.
4. Buchbinder SP, Metch B, Holte SE, et al. Determinants of enrollment in a preventive HIV vaccine trial: hypothetical versus actual willingness and barriers to participation. J Acquir Immune Defic Syndr. 2004;36:604-612.
5. Strauss RP, Sengupta S, Kegeles S, et al. Willingness to volunteer in future preventive HIV vaccine trials: issues and perspectives from three U.S. communities. J Acquir Immune Defic Syndr. 2001;26:63-71.
6. Hays RB, Kegeles SM. Factors related to the willingness of young gay men to participate in preventive HIV vaccine trials. J Acquir Immune Defic Syndr Hum Retrovirol. 1999;20:164-171.
7. Koblin BA, Heagerty P, Sheon A, et al. Readiness of high-risk populations in the HIV Network for Prevention Trials to participate in HIV vaccine efficacy trials in the United States. AIDS. 1998;12:785-793.
8. HIV Vaccine Trials Network Demographic Statistics, Seattle, WA: August 30, 2004.
9. Harr CD, Judson FN, Gorse GJ, et al. Recruitment and baseline epidemiologic profile of participants in the first phase 3 HIV vaccine efficacy trial. J Acquir Immune Defic Syndr. 2004;37:1385-1392.
10. Giuliano AR, Mokuau N, Hughes C, et al. Participation of minorities in cancer research: the influence of structural, cultural, and linguistic factors. Ann Epidemiol. 2000;10:S22-S34.
11. Connell CM, Shaw BA, Holmes SB, et al. Caregivers' attitudes toward their family members' participation in Alzheimer disease research: implications for recruitment and retention. Alzheimer Dis Assoc Disord. 2001;15:137-145.
12. Slater M. Choosing audience segmentation strategies and methods for health communication. In: Maibach E, Parrott R. Designing Health Messages: Approaches From Communication Theory and Public Health Practice. Sage, CA: Thousand Oaks; 1995:186-198.
13. Slater M, Flora J. Health lifestyles: audience segmentation analysis for public health interventions. Health Educ Q. 1991;18:221-233.
14. Slater MD. Theory and method in health audience segmentation. J Health Commun. 1996;1:267-283.
15. Weinstein A. Market Segmentation: Using Demographics, Psychographics and Other Niche Marketing Techniques to Predict and Model Customer Behavior. Chicago: Probus; 1994.